Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gliatech receives grant for histamine H3 receptor antagonists

March 3, 1997

Novel polyamines fromTeva

March 3, 1997

NeoTherapeutics seeks approval for trials on neurological drug

Feb. 28, 1997

MS&D describes nonpeptide tachykinin antagonists

Feb. 28, 1997

Sigma-receptor antagonists disclosed by Taisho

Feb. 28, 1997

Taiho discloses anxiolytics

Feb. 28, 1997

Riluzole now available in France

Feb. 27, 1997

Glaxo Wellcome evaluates ondansetron alone and in combination for emesis

Feb. 27, 1997

Taisho discloses promoters of NGF production

Feb. 27, 1997

Pfizer licenses potential stroke therapy

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.